Cholecystokinin (CCK) is released from enteroendocrine cells following ingestion of nutrients and induces multiple effects along the gastrointestinal tract, including gastric relaxation and shortterm satiety. We used whole cell patch clamp and immunohistochemical techniques in rat brainstem slices to characterize the effects of CCK. In 45% of the neurons of nucleus tractus solitarius subnucleus centralis (cNTS), perfusion with the sulfated form of CCK (CCK8s) increased the frequency of spontaneous excitatory currents (sEPSCs) in a concentration-dependent manner (1-300nM). The threshold for the CCK-8s excitatory effect was 1nM, the EC 50 was 20nM and E max was 100nM. The excitatory effects of CCK-8s were still present when the slices were preincubated with tetrodotoxin or bicuculline or when the recordings were conducted with Cs + electrodes. Pretreatment with the CCK-A receptor antagonist, lorglumide (1µM), antagonized the effects of CCK-8s, while perfusion with the CCK-B preferring agonist CCK-8 non sulfated (CCKns, 1µM) did not affect the frequency of sEPSCs. Similarly, pretreatment with the CCK-B receptor antagonist, triglumide (1µM), did not prevent the actions of CCK8s. While the majority (i.e. 76%) of CCK8s unresponsive cNTS neurons had a bipolar somata shape and were TH-IR negative, no differences were found in either the morphological or the neurochemical phenotype of cNTS neurons responsive to CCK8s. Our results suggest that the excitatory effects of CCK8s on terminals impinging on a subpopulation of cNTS neurons are mediated by CCK-A receptors; these responsive neurons, however, do not have morphological or neurochemical characteristics that automatically distinguish them from non responsive neurons.
INTRODUCTION
Vagal sensory afferent fibers enter the brainstem via the tractus solitarius and terminate in a viscerotopically organized manner in the subnuclei of the nucleus tractus solitarius (NTS) (1; 4; 11; 41; 42) . The same NTS subnucleus may receive information from gastrointestinal, cardiovascular and/or respiratory areas (4) . The subnucleus centralis (cNTS), which is located adjacent to the tractus solitarius, however, receives inputs from vagal afferent fibers originating almost exclusively from the esophagus (1; 11; 22; 41) , thus making it an excellent model for the study of gastrointestinal second order neurons.
We have shown that esophageal distension increases the firing rate of neurons in the cNTS and induces gastric relaxation (41). More recently, we have reported that esophageal distention induces cFos activation in the majority of cNTS neurons that express tyrosine-hydroxylase immunoreactivity (TH-IR) (44). A vast array of studies have shown that sensory vagal information to NTS neurons is excitatory and uses, principally, excitatory amino acids such as glutamate (2; 18; 22; 24; 26; 29; 46; 51) .
Cholecystokinin (CCK) is released from small intestinal enteroendocrine cells in response to nutrients (27; 33; 40) . CCK then, mainly via CCK-A but possibly also via CCK-B receptors, induces multiple effects along the gastrointestinal tract, including gastric relaxation, as well as reduction of food intake (32; 36; 37; 40; 50) . A vast amount of literature supports the possibility that CCK acts in a paracrine manner on vagal sensory neurons (5; 6; 15; 36) . Physiological and pharmacological data, however, also support the effects of CCK on sites other than peripheral vagal afferent terminals, including the nodose ganglion itself and the dorsal vagal complex (DVC, i.e. the dorsal motor nucleus of the vagus, DMV, the NTS and area postrema) (7; 31; 38; 39; 45; 52) .
In an electrophysiological study of DVC neurons, Brancheraux et al. reported that application of CCK induced either an excitation, an inhibition or a biphasic excitatory-inhibitory effect (8; 9) . These authors also concluded that the effects of CCK8s were determined by activation of both CCK-A and CCK-B receptors, however, their recordings did not distinguish between NTS and DMV neurons.
We have reported recently that CCK-8s excites subpopulations of DMV neurons via an action mediated by CCK-A receptors (52) . In the same study we showed that the effects of CCK-8s were attenuated by pretreatment with the synaptic transmission blocker tetrodotoxin, suggesting that synaptic inputs onto DMV neurons or onto neurons, such as NTS cells, projecting to DMV could also be excited by CCK-8s.
The aims of this work were to 1) characterize the pharmacological response to exogenous CCK-8s of terminals impinging on cNTS neurons; and, 2) characterize the cNTS neurons responsive and unresponsive to CCK with respect to their morphological and TH-IR neurochemical properties.
METHODS
Research reported in the present manuscript conforms fully to National Institute of Health guidelines and was approved by the Pennington Biomedical Research Center-LSU System Animal Care and Use Committee.
Electrophysiology:
The method of slicing the brainstem has already been described (49). Briefly, 25-35 days old Sprague-Dawley rats of either sex were anesthetized with halothane (abolition of the foot pinch withdrawal reflex) before being killed by severing the blood vessels in the chest. The brainstem was removed and glued to the platform of a vibratome, and three coronal slices (300 µm-thick) were cut starting from the posterior area postrema moving rostrally. The slices were stored at least one hour in oxygenated (95% O 2 /5% CO 2 ) Krebs' solution (see Solution composition) at 30 °C before use. A single slice was then transferred to a perfusion chamber (volume 500µl; Michigan Precision Instruments, Parma, MI), kept in place with a nylon mesh and maintained at 35±1 o C by perfusion with warmed Krebs' solution at a rate of 2.5-3.0 ml min -1 .
Whole cell recordings were conducted on putative cNTS neurons identified as per their location in close proximity (within 100µm) to the tractus solitarius at a level encompassing the mid-rostral area postrema and the portion of NTS up to approximately 0.5 mm rostral of the anterior portion of the area postrema itself. Recordings were made with patch pipettes (6-8 M resistance) filled with a potassium or cesium gluconate solution (see Solution composition) by using an Axoclamp 2B amplifier (Axon Instruments, Union City, CA). Data were sampled at 10 kHz and filtered at 2 kHz, digitized via a Digidata 1200C interface (Axon Instr.), acquired, stored, and analyzed on an IBM PC utilizing pClamp 8 software (Axon Instr) and Mini Analysis software (Jaejin Software, Leonia, NJ).
Recordings were accepted only if the series resistance was <15 M . In addition, the action potential evoked after injection of depolarizing current must have had amplitude of at least 50 mV and the membrane potential had to return to the baseline value after the action potential afterhyperpolarization (AHP).
Drugs were applied to the bath via a series of manually operated valves at concentrations shown previously to be effective. Neurons were allowed to recover fully between additions of agonists (minimum wash-out period of 10 minutes). Antagonists were superfused for at least 5 minutes prior to re-application of the agonist. Each neuron served as its own control when assessing the effects of antagonists, i.e., in each neuron the effect of any drug was assessed before and after antagonist. Cells were classified as CCK-8s responsive if perfusion with 100nM CCK-8s increased the frequency of spontaneous excitatory postsynaptic currents (sEPSC) by a minimum of 50% above baseline. The concentration-response curve for CCK-8s was constructed from neurons in which at least three concentrations were tested.
At the end of recording, Neurobiotin® (2.5% w/v) was injected into the neuron (0.3nA, 600ms duration depolarizing pulse every 2 sec) for 15-20 minutes to permit post-fixation reconstruction.
Slices were then immersed in Zamboni's fixative (see Solution Composition) and stored at 4°C until analysed.
Immunohistochemistry:
The slice was cleared of fixative by washing it repeatedly in PBS before incubation for 18-24 hours at 4°C in Phosphate Buffer Solution-Triton-X bovine serum albumin (PBS-TX-BSA see Solution Composition) containing mouse anti-tyrosine hydroxylase (1:1000). Slices were then washed in PBS-TX and incubated for two hours at 37°C with PBS-TX-BSA containing secondary antibodies (goat anti-mouse conjugated with Alexa 488, FITC-1:500, TH staining; and, streptavidin-Texas Red, 1:100 to visualize the neurobiotin®-filled neuron). The slices were then mounted in Fluoromount-G® (Southern Biotechnology Associates, Birmingham, AL) to reduce fading and analysed for immunofluorescence using a Zeiss 510 confocal scanning laser microscope equipped with a Kr/Ar-ion laser with filters for the selective visualization of Texas red and FITC.
Morphological Reconstructions:
Slices were cleared of fixative in PBS-TX and kept at 4°C until the injected Neurobiotin® was visualized using a cobalt-nickel enhancement of the Avidin D-horseradish peroxidase (Avidin D-HRP) technique as described previously (12; 30). Briefly, slices were incubated in Avidin D-HRP solution (see Solution Composition) for 2 hours. Following 15 min rinse in PBS and subsequent incubation for 15-20 min in Avidin D-HRP and DAB solutions (see Solution Composition), the slice was incubated for 15 additional minutes in the presence of 3% H 2 O 2 . The slice was then rinsed in PBS, placed on a gelatin-coated coverslip, air dried, cleared in alcohol and xylene, and mounted in Permount®.
Three-dimensional reconstructions of individual Neurobiotin®-labeled neurones, digitized at a final magnification of x600, were made using Neurolucida® software (Microbrightfield Inc., Williston, VT, USA). Each reconstruction was verified using the software for "mathematical completeness". The optical and physical compression of the slice that may occur is corrected by rescaling the section to 300µm (the original thickness at time of sectioning).
The morphological features that were assessed include: soma area and diameter, form factor (a measure of circularity for which a value of 1 indicates a perfect circle and 0 indicates a line; form factor = 4πa × 1/p 2 , where a = soma area and p = the perimeter of the soma in the horizontal plane), whether the cell has bipolar or multipolar somata, number of segments (i.e. branching of dendrites), branch order and extension in the X and Y axes. Data analysis was performed as described previously (12; 30).
Solutions composition:
Krebs' (in mM): 126 NaCl, 25 NaHCO 3 , 2. 
Drugs and chemical:
Tyrosine hydroxylase antibodies were purchased from Immunostar (Hudson, WI); Alexa conjugated secondary antibodies were purchased from Molecular Probes (Eugene, OR); Neurobiotin® was purchased from Vector Labs (Burlingame, CA). All other drugs were purchased from Sigma (St. Louis, MO, USA). Stock solutions were prepared freshly and diluted to the final concentration in Krebs' solution just before use.
Statistical Analysis:
Results are expressed as means ± S.E.M. with significance defined as P < 0.05. Results were compared before and after drug administration, with each neuron serving as its own control (Student's paired t test). Intergroup comparisons were conducted using the Student's grouped t test or the χ 2 test.
RESULTS
We conducted electrophysiological studies on 187 neurons of the cNTS; in 19 of these neurons we obtained complete morphological reconstructions, while in a further 96 neurons we were able to obtain the reconstruction only of the somata shape. We also analyzed the neurochemical phenotype of 54 of the recorded cNTS neurons.
CCK8s increases the frequency of EPSC via CCK-A receptors
When recorded at a holding potential of -50mV, sEPSC had a frequency of 1.5±0.16 events s -1 and 27.2±1.26pA amplitude (N=173). These events were abolished by perfusion with 1mM kynurenic acid (N=8), suggesting they were mediated by glutamate. We also analysed the effects of CCK-8s in the presence of the synaptic transmission blocker tetrodotoxin (TTX). In five cells, 100nM CCK-8s increased the frequency and amplitude of the events from 1.8±0.87 to 9.2±3.06 events s -1 and from 28.6±1.53 to 40.5±5.30 pA, in control and CCK-8s, respectively (P<0.05 for both). Following five minutes perfusion with TTX (0.3-1µM), subsequent perfusion with 100nM CCK-8s in the presence of TTX increased the frequency of miniature EPSC (mEPSC) from 1.7±1.11 to 3.5±1.08 events s -1 (P<0.05 vs TTX alone; P>0.05 vs CCK-8s alone). In these cells, however, the amplitude of the mEPSCs was not altered by perfusion with CCK-8s (29.8±2.15 and 32.6±3.60 pA in TTX alone and in TTX+CCK-8s, respectively (P>0.05). These data suggest that the presynaptic site of action of CCK-8s is directed on terminals apposing cNTS neurons.
In some cNTS neurons, we observed the presence of spontaneous inhibitory postsynaptic currents (IPSCs) that were sensitive to bicuculline. In four cells, perfusion with 100nM CCK-8s increased the frequency of sEPSC from 3.6±2.37 to 18.4±3.82 events s -1 (p<0.05) but did not alter the frequency or amplitude of sIPSC (1±0.18 and 0.8±0.09 events s -1 and 33±8.24 and 36±12.21pA in control and CCK-8s, respectively; p>0.05; V hold =-35mV).
In a further six neurons, perfusion with 100nM CCK-8s increased the frequency of sEPSC from 1.4±0.20 to 13.3±3.9 events s -1 (p<0.05). Similarly, after ten minutes perfusion with 1µM TTX and/or 50µM bicuculline, perfusion with CCK-8s increased the frequency of mEPSC from 1.3±0.27 to 9.2±3.15 events s -1 (p<0.05). Subsequent perfusion of these cells with 10µM CNQX and 30µM AP-5 completely abolished mEPSC. These data suggest that the effects of CCK-8s involve an increase in glutamatergic but not GABAergic synaptic transmission.
The response to CCK-8s did not show tachyphylaxis. In four cells, perfusion with 100nM CCK-8s increased the frequency of sEPSC from 1.7±1.08 to 9.4±3.28 events s -1 , in control and CCK-8s, respectively (P<0.05), following five minutes wash out, a second administration of 100nM CCK-8s increased the frequency of sEPSC from 2.3±1.5 to 10.1±5.15 events s -1 (P<0.05 vs control; P>0.05 vs the first administration of CCK-8s).
In six cells that responded to 100nM CCK-8s with an increase in sEPSC frequency from 1.6±0.43 to 12.6±3.02 events s -1 in control and CCK-8s respectively (P<0.05), five minutes perfusion with the selective CCK-A receptor antagonist, lorglumide (1µM), which per se did not have any effect on the frequency of sEPSC, antagonized the effects of CCK-8s. The frequency of sEPSC was 1.7±0.63 and 1.7±0.69 events s -1 in the presence of lorglumide alone and lorglumide+CCK-8s, respectively (P>0.05; Figure 2 ). Conversely, pretreatment with the selective CCK-B receptor antagonist, triglumide (1µM), failed to antagonize the CCK-8s induced increase in sEPSC frequency.
In five cells that responded to CCK-8s with an increase in sEPSC frequency from 1.7±0.50 to 11.9±3.62 events s -1 , in control and CCK-8s respectively (P<0.05), in the presence of triglumide, CCK-8s increased sEPSC frequency from 1.8±0.62 to 8.10±2.25 events s -1 in triglumide alone and triglumide+CCK-8s, respectively (P<0.05 vs triglumide alone; P>0.05 vs CCK-8s alone; Figure 2 ). These data suggest that the excitatory effects of CCK-8s are mediated by CCK-A, but not CCK-B, receptors.
The involvement of CCK-A receptors only in the CCK-8s mediated increase of sEPSC frequency was further supported by experiments conducted with the CCK-B preferring agonist non CCKns. In three cells in which CCK-8s increased the frequency of sEPSC from 1.3±0.6 to 6.9±3.39 events s -1 , perfusion with 1µM CCKns had no effect on the sEPSC frequency (1.3±0.6 to 1.15 ± 0.5 events s -1 in control and CCKns, respectively)( Figure 3 ).
Morphological and neurochemical characteristics of cNTS neurons responsive or unresponsive to CCK8s
Thirty-seven of the 96 cNTS neurons (39%) in which we were able to reconstruct the somata shape responded to CCK8s with an increase in sEPSC frequency, 16 of those 37 neurons (43%) had a multipolar soma shape, the other 21 neurons (57%) had a bipolar soma shape. Forty-five of the 59 cNTS neurons (76%) unresponsive to CCK8s had a bipolar soma shape, the remaining 14 (24%) were instead multipolar (P<0.05 vs responsive neurons, χ 2 test)( figure 4 ).
In the 19 cells in which we were able to conduct a complete morphological characterization, the morphological characteristics of cNTS neurons did not differ, apart from the number of segments, Fifteen of the 54 cNTS neurons (26%) in which we were able to conduct both a pharmacological and neurochemical characterization were TH-IR positive, the remaining 39 neurons (74%) were, instead, TH-IR negative. Of the 15 neurons responsive to CCK-8s in which we were able to conduct also an analysis of TH-IR, seven of them (47%) were TH-IR positive and eight (53%) were TH-IR negative. Conversely, thirty-two (82%) of the neurons non-responsive to perfusion with 100nM CCK-8s were TH-IR negative and only seven (18%) were TH-IR positive (P<0.05 χ 2 test; figure 5 ).
DISCUSSION
In the present manuscript we have shown that: 1) perfusion with CCK-8s increases the frequency of glutamatergic spontaneous and miniature EPSCs in 45% of cNTS neurons; 2) perfusion with CCK-8s does not affect the frequency of sIPSC; 3) the CCK-8s effects on EPSCs are mediated by CCK-A receptors only; and, 4) cNTS neurons responsive to CCK-8s do not have unique morphological or immunocytochemical (i.e. TH-IR) characteristics that distinguish them from neurons that are unresponsive to CCK-8s, although the unresponsive neurons are more likely to have a bipolar soma shape and to be TH-IR negative.
Our data also suggest that functional CCK-A, but not CCK-B, receptors, are present on a subpopulation of fibers impinging on cNTS neurons. It is possible that by modulating the glutamatergic inputs onto NTS these CCK-A receptors contribute to the physiological role of CCK in the central that perfusion with CCK-8s increased the frequency of sEPSC also when the recordings were conducted with intracellular solutions containing cesium, which blocks the potassium currents affected by CCK-8s on postsynaptic membranes of brainstem vagal neurons (8; 52) . These data, however, do not clarify whether CCK-8s affected glutamatergic terminals apposing directly the cNTS neuron or acted at other remote sites and were recorded on the cNTS neuron because of the intact glutamatergic circuitry in the slice. To circumvent partially the latter possibility, we conducted a series of experiments in the presence of the synaptic blocker tetrodotoxin (TTX). Following pretreatment with TTX, perfusion with CCK-8s still increased the frequency of mEPSCs. Some cNTS neuron also displayed the presence of bicuculline-sensitive GABAergic spontaneous currents; these sIPSC, however, were not affected by perfusion with CCK-8s. These data are strongly suggestive of a presynaptic effect of CCK-8s on glutamatergic terminals, some of which are very likely to be of vagal origin, apposing cNTS neurons directly, without interposed local interneurons. This is not meant to categorically exclude the possibility that CCK-8s is exciting sites remote to the recorded neuron but rather to support our interpretation (see below) that CCK-8s mechanisms of action involves also vagal afferent terminals within the brainstem.
The presynaptic effects of CCK-8s were mediated by activation of CCK-A receptors only. In fact, pretreatment with the selective CCK-A receptor antagonist lorglumide prevented the increase in spontaneous EPSCs induced by 100nM CCK-8s. Conversely, pretreatment with the selective CCK-B receptor antagonist triglumide was ineffective in attenuating the excitatory effects of CCK-8s. The lack of involvement of CCK-B receptors was supported further by the data showing that the CCK-B preferring agonist CCK-ns, even when used at concentrations as high as 1µM, was ineffective in modulating spontaneous EPSCs whose frequency was increased by CCK-8s.
Our data demonstrating that the effects of CCK-8s were mediated by CCK-A receptors are in agreement with results showing that, overall, the satiety and gastrointestinal effects of CCK-8s are mediated via CCK-A receptors (19; 28; 32; 37; 38) . Of particular relevance are the data showing that were more likely to have a bipolar somata shape and to be TH-IR negative. These data would suggest that esophageal distention activates a subpopulations of cNTS neurons that is neurochemically more homogeneous than that activated by CCK-8s.
The postprandial plasma concentration of CCK is in the picomolar range (47) and a decrease in gastric motility was observed following i.v. injection of 10pmoles CCK-8s (in a 250g rat, this would be the approximately equivalent to a 7nM concentration) (48) . A threshold of 1nM, as reported in the present manuscript, would give physiological, rather than pharmacological, relevance to our data. In fact, it is well known that in in vitro preparations there is a shift to the right of the concentrationdependence to agonist by one or more orders of magnitude when compared to in in vivo preparations (17) . Indeed, the most commonly used concentrations of CCK-8s in in vitro experiments are 100nM or higher (3; 8; 9; 35; 45) . Furthermore, experiments conducted in slices would undoubtedly damage some afferent fibers, rendering them less responsive to modulatory agents.
Despite the potential physiological importance of our data, it is not clear how CCK would reach the brainstem to exert its actions since CCK does not readily cross the blood brain barrier. The dorsal vagal complex (DVC; i.e. NTS + DMV), however, has a rather porous blood brain barrier (13) that allows the passage of molecules as big as, among others, TNFα or pancreatic polypeptides (14; 16; 43) . Functional evidence that CCK crosses the "leaky" blood brain barrier to affect vagal neurons has also been provided by several authors, (21; 38; 52). In fact, lesions of vagal pathways did not prevent the effects of systemic CCK administration on the NTS-nigral circuit, which was, instead, interrupted by lesion of medullary nuclei (21). Also, the short term satiety effects of CCK are antagonized by devazepide, a selective CCK-A receptor antagonist that crosses the blood brain barrier, but not by A70104, a selective CCK-A antagonist that does not cross the blood brain barrier (38) and, finally, i.p. CCK injection at low concentrations phosphorylates (i.e. activates) CCK-A receptors in the dorsal vagal complex (52) .
It is also possible that the effects of CCK on brainstem nuclei are determined by CCK acting as a local neurotransmitter or neuromodulator. Indeed, CCK-containing neural projections originating from both the NTS itself or, likely, the hypothalamus or amygdala are present throughout the rostrocaudal extent of the vagal complex (25) .
In summary, although the source of CCK in NTS has not been elucidated, our results support a possible physiologically relevant role to CCK as a neurotransmitter or neuromodulator, acting on CCK-A receptors, to excite indirectly subpopulations of cNTS neurons. When combined, these data seem to support the hypothesis that the actions of CCK-8s cannot be ascribed exclusively to activation of vagal fibers in the periphery, and a CNS-brainstem component should be considered. 
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